Prognostic implications of dynamic serum lactate dehydrogenase assessments in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhou, Guan Qun ^a   Ren, Xian Yue ^a   Mao, Yan Ping ^a   Chen, Lei ^a   Sun, Ying ^a   Liu, Li Zhi ^a   Li, Li ^a   Lin, Ai Hua ^b   Mai, Hai Qiang ^a   Ma, Jun ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LACTATE DEHYDROGENASE;

ADOLESCENT; ADULT; AGED; BLOOD; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PATIENT OUTCOME ASSESSMENT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84959484939     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22326     Document Type: Article

References (27)

1. Jemal, A. et al. Global cancer statistics. CA: a cancer journal for clinicians 61, 69-90, doi: 10.3322/caac.20107 (2011).
2. Wilson, C. P. The approach to the nasopharynx. Proceedings of the Royal Society of Medicine 44, 353-358 (1951).
3. Lee, A. W. et al. The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement. Oral oncology 48, 1007-1013, doi: 10.1016/j.oraloncology.2012.03.022 (2012).
4. Liaw, C. C. et al. Serum lactate dehydrogenase level in patients with nasopharyngeal carcinoma. Acta oncologica 36, 159-164 (1997).
5. Ma, B. B. et al. Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy. Cancer 101, 776-781, doi: 10.1002/cncr.20430 (2004).
6. Zhou, G. Q. et al. Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis. International journal of radiation oncology, biology, physics 82, e359-365, doi: 10.1016/j.ijrobp.2011.06.1967 (2012).
7. Wan, X. B. et al. High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma. European journal of cancer 49, 2356-2364, doi: 10.1016/j.ejca.2013.03.008 (2013).
8. Tao, C. J. et al. Prognostic scoring system for locoregional control among the patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy. Chinese journal of cancer 32, 494-501, doi: 10.5732/cjc.013.10121 (2013).
9. Cheng, S. H. et al. A prognostic scoring system for locoregional control in nasopharyngeal carcinoma following conformal radiotherapy. International journal of radiation oncology, biology, physics 66, 992-1003, doi: 10.1016/j.ijrobp.2006.06.006 (2006).
10. Edge, S. B. et al. AJCC cancer staging manual. Vol. 649 (Springer, New York, 2010).
11. Li, W. F. et al. Locoregional extension patterns of nasopharyngeal carcinoma and suggestions for clinical target volume delineation. Chinese journal of cancer 31, 579-587, doi: 10.5732/cjc.012.10095 (2012).
12. Shanmugaratnam, K. Nasopharyngeal carcinoma: epidemiology, histopathology and aetiology. Annals of the Academy of Medicine, Singapore 9, 289-295 (1980).
13. Chen, M. et al. Impact of plasma Epstein-Barr virus-DNA and tumor volume on prognosis of locally advanced nasopharyngeal carcinoma. BioMed research international 2015, 617949, doi: 10.1155/2015/617949 (2015).
14. Li, A. C. et al. Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensitymodulated radiotherapy. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine, doi: 10.1007/s13277-015-3574-0 (2015).
15. Lee, A. W. et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 23, 6966-6975, doi: 10.1200/JCO.2004.00.7542 (2005).
16. Lai, S. Z. et al. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? International journal of radiation oncology, biology, physics 80, 661-668, doi: 10.1016/j.ijrobp.2010.03.024 (2011).
17. Guo, R. et al. Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinomə Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 104, 294-299, doi: 10.1016/j.radonc.2012.09.001 (2012).
18. Lo, Y. M. et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer research 59, 1188-1191 (1999).
19. Cheng, S. H. et al. Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials. International journal of radiation oncology, biology, physics 50, 717-726 (2001).
20. Liu, N. et al. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. The Lancet. Oncology 13, 633-641, doi: 10.1016/S1470-2045(12)70102-X (2012).
21. Jin, Y. et al. Serum lactic dehydrogenase strongly predicts survival in metastatic nasopharyngeal carcinoma treated with palliative chemotherapy. European journal of cancer 49, 1619-1626, doi: 10.1016/j.ejca.2012.11.032 (2013).
22. Armstrong, A. J., George, D. J. & Halabi, S. Serum lactate dehydrogenase predicts for overall survival benefit in patients with metastatic renal cell carcinoma treated with inhibition of mammalian target of rapamycin. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 30, 3402-3407, doi: 10.1200/JCO.2011.40.9631 (2012).
23. Wimazal, F. et al. Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO 19, 970-976, doi: 10.1093/annonc/mdm595 (2008).
24. Firth, J. D., Ebert, B. L. & Ratcliffe, P. J. Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements. The Journal of biological chemistry 270, 21021-21027 (1995).
25. Durand, R. E. Keynote address: the influence of microenvironmental factors on the activity of radiation and drugs. International journal of radiation oncology, biology, physics 20, 253-258 (1991).
26. Kim, J. W. & Dang, C. V. Cancer's molecular sweet tooth and the Warburg effect. Cancer research 66, 8927-8930, doi: 10.1158/0008-5472.CAN-06-1501 (2006).
27. Yu, X. et al. Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma. Cell death & disease 4, e634, doi: 10.1038/cddis.2013.153 (2013).